rs914754937
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001159699.2(FHL1):c.737-9T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,170,211 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 72 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00019 ( 0 hom., 7 hem., cov: 21)
Exomes 𝑓: 0.00017 ( 0 hom. 65 hem. )
Consequence
FHL1
NM_001159699.2 intron
NM_001159699.2 intron
Scores
2
Splicing: ADA: 0.00008933
2
Clinical Significance
Conservation
PhyloP100: 0.586
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant X-136209862-T-C is Benign according to our data. Variant chrX-136209862-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 391549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000192 (21/109207) while in subpopulation EAS AF= 0.000575 (2/3480). AF 95% confidence interval is 0.000255. There are 0 homozygotes in gnomad4. There are 7 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159702.3 | c.889-9T>C | intron_variant | ENST00000394155.8 | NP_001153174.1 | |||
FHL1 | NM_001159699.2 | c.737-9T>C | intron_variant | ENST00000370683.6 | NP_001153171.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000394155.8 | c.889-9T>C | intron_variant | 5 | NM_001159702.3 | ENSP00000377710.2 | ||||
FHL1 | ENST00000370683.6 | c.737-9T>C | intron_variant | 1 | NM_001159699.2 | ENSP00000359717.1 |
Frequencies
GnomAD3 genomes AF: 0.000192 AC: 21AN: 109163Hom.: 0 Cov.: 21 AF XY: 0.000221 AC XY: 7AN XY: 31681
GnomAD3 genomes
AF:
AC:
21
AN:
109163
Hom.:
Cov.:
21
AF XY:
AC XY:
7
AN XY:
31681
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000166 AC: 28AN: 168269Hom.: 0 AF XY: 0.000223 AC XY: 13AN XY: 58243
GnomAD3 exomes
AF:
AC:
28
AN:
168269
Hom.:
AF XY:
AC XY:
13
AN XY:
58243
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000172 AC: 183AN: 1061004Hom.: 0 Cov.: 30 AF XY: 0.000189 AC XY: 65AN XY: 344356
GnomAD4 exome
AF:
AC:
183
AN:
1061004
Hom.:
Cov.:
30
AF XY:
AC XY:
65
AN XY:
344356
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000192 AC: 21AN: 109207Hom.: 0 Cov.: 21 AF XY: 0.000221 AC XY: 7AN XY: 31737
GnomAD4 genome
AF:
AC:
21
AN:
109207
Hom.:
Cov.:
21
AF XY:
AC XY:
7
AN XY:
31737
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 28, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at